BioCentury
ARTICLE | Company News

Carmot, Sunesis deal

February 15, 2010 8:00 AM UTC

Carmot received an exclusive license to Sunesis' Chemotype Evolution fragment-based lead discovery technology. Carmot will use the technology to identify compounds to treat inflammatory, metabolic, an...